1. Optical coherence tomography angiography characteristics of choroidal neovascularization requiring varied dosing frequencies in treat-and-extend management: An analysis of the AVATAR study
- Author
-
Atsuro Uchida, Sunil K. Srivastava, Peter K. Kaiser, Amy Babiuch, Ming Hu, Katherine Talcott, Rishi P Singh, Justis P. Ehlers, and Aleksandra Rachitskaya
- Subjects
Pigments ,Male ,Vascular Endothelial Growth Factor A ,genetic structures ,Physiology ,Computed Tomography Angiography ,Angiogenesis Inhibitors ,Cardiovascular Medicine ,Cardiovascular Physiology ,Diagnostic Radiology ,Macular Degeneration ,0302 clinical medicine ,Foveal ,Vasculogenesis ,Medicine and Health Sciences ,Morphogenesis ,Drug Dosage Calculations ,Prospective Studies ,Cardiovascular Imaging ,Geriatric Ophthalmology ,Tomography ,Materials ,Aged, 80 and over ,Multidisciplinary ,medicine.diagnostic_test ,Radiology and Imaging ,Retinal Degeneration ,Angiography ,Middle Aged ,Treatment Outcome ,medicine.anatomical_structure ,Choroidal neovascularization ,Physical Sciences ,Retinal Disorders ,Medicine ,Female ,Anatomy ,medicine.symptom ,Tomography, Optical Coherence ,Research Article ,medicine.medical_specialty ,Imaging Techniques ,Ocular Anatomy ,Science ,Materials Science ,Research and Analysis Methods ,Retina ,03 medical and health sciences ,Ocular System ,Diagnostic Medicine ,Ophthalmology ,medicine ,Humans ,Dosing ,Aged ,Choroid ,business.industry ,Biology and Life Sciences ,Optical coherence tomography angiography ,Macular degeneration ,medicine.disease ,Choroidal Neovascularization ,eye diseases ,Regimen ,Geriatrics ,Macular Disorders ,030221 ophthalmology & optometry ,Eyes ,sense organs ,business ,Head ,030217 neurology & neurosurgery ,Developmental Biology - Abstract
PurposeTo evaluate optical coherence tomography angiography (OCTA) characteristics of choroidal neovascularization (CNV) in eyes requiring different treatment frequency of anti-vascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration (NVAMD).DesignProspective observational case series.MethodsSubjects who had undergone anti-VEGF treatment for NVAMD in the AVATAR study were subdivided into 3 groups depending on required anti-VEGF dosing: (i) treat-and-extend requiring every 4-6 weeks dosing (TEq4-6w), (ii) treat-and-extend requiring every 7-12 weeks dosing (TEq7-12w), (iii) eyes not requiring injection within last 12 months (PRN >12mo). OCTA images were evaluated for the morphological characteristics of CNV and the choriocapillaris flow void.ResultsStudy consisted 40 eyes of 31 patients with a mean age of 79.9 ± 6.2 years. CNV morphology analysis on OCTA was feasible in 29 (73%) eyes. Ninety percent of CNVs in TEq7-12w group were irregular in shape involving foveal center, while 67% of CNVs in PRN>12mo group were circular in shape sparing foveal center. Among three groups, statistical difference was found in CNV shape (P = .012) and CNV location (P = .003), while no statistical difference was found in the CNV area (P = .14), vessel density (P = .19), presence of core vessels (P = .23), the presence of small margin loops (P = .20), large margin loops (P = .14), CNV maturity (P = .40), or the mean percentage of choriocapillaris area with flow void (P = .66).ConclusionThe combination of CNV sparing the foveal center with higher circularity may suggest a clinically inactive CNV following initial anti-VEGF therapy. We found minimal distinguishing OCTA characteristics between those eyes that required ongoing therapy with the treat-and-extend regimen. More research is needed to identify specific CNV characteristics on OCTA that may become a useful tool for the management of NVAMD and timing of treatment.
- Published
- 2019